CesselliDBeltramiAPRigoS. Multipotent progenitor cells are present in human peripheral blood. Circ Res. 2009;104:1225-1234.
2.
GentilePDe AngelisBPasinM. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg. 2014;25:267-272.
3.
GentilePOrlandiAScioliMG. A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med. 2012;1:341-351.
4.
HaCWParkYB. Mesenchymal stem cell injection for osteochondral lesions of the talus: letter to the editor. Am J Sports Med. 2014;42:NP19-NP20.
5.
KimYSKohYG. Mesenchymal stem cell injection for osteochondral lesions of the talus: response. Am J Sports Med. 2014;42:NP20-NP21.
6.
KimYSParkEHKimYCKohYG. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013;41:1090-1099.
7.
LockeMWindsorJDunbarPR. Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg. 2009;79:235-244.
TholpadySSLlullROgleRCRubinJPFutrellJWKatzAJ. Adipose tissue: stem cells and beyond. Clin Plast Surg. 2006;33:55-62, vi.
10.
WickhamMQEricksonGRGimbleJMVailTPGuilakF. Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res. 2003;412:196-212.
11.
ZukPAZhuMMizunoH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-228.